It's mission - to expand, sometimes drastically - the life expectancy of dogs, giving them more time with their owners.
"The way to think about it is pulling out the healthy middle years. Those years where your dog wants to go to the park, is bounding around - can we have more of those?" said Halioua. The idea behind it is that dog owners will be able to give their animals a series of drugs, kind of like heartworm pills, over the course of their lives.Halioua's team has raised over $65 million in venture capital.Loyal hopes to get FDA approval for two drugs by 2025.
"It's something that'll be given to the dog every three to six months that will release a drug over time at a consistent rate," said Halioua.Sherri Franklin is the CEO of Muttville Senior Dog Rescue - a shelter that's worked with Loyal for some of their studies.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »